Ista Investor Sues To Block $500M Bausch & Lomb Deal

Law360, Wilmington (March 30, 2012, 6:49 PM EDT) -- An Ista Pharmaceuticals Inc. shareholder on Thursday challenged Bausch & Lomb Inc.'s $500 million bid for the eye care drug manufacturer in a class action alleging the offer is too low and the result of a flawed process.

The companies announced the $9.50 per share deal Monday, two months after Ista warded off a considerably lower offer from Canadian drugmaker Valeant Pharmaceuticals International Inc. with a poison pill takeover defense.

But Bausch & Lomb's offer is still inadequate, according to a complaint lodged by Helene Hutt...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.